Pharmaceutical Associates Inc, a US-based company that manufactures and markets generic liquid pharmaceuticals, announced on Wednesday, June 16, that it has named Dr. Suketu Sanghvi as its new chief scientific officer.
In the new role, Dr. Sanghvi will head PAI's Research and Development efforts that are focused on oral liquid and sterile injectable products.
Dr. Sanghvi has served as chief scientific officer at Scienture Inc. He was managing the R&D portfolio for Endo Pharmaceuticals and Par Pharmaceutical. He has served in senior scientific roles at Novel Laboratories and Forest Laboratories.
Dr. Sanghvi holds a PhD in Pharmacy with a focus in drug formulation and pharmaceutics from the University of Toronto.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer